17
Apr
2024

Sonoma Pharmaceuticals

Exhibitor at CPHI Japan 2024 stand 5K-03
About Us

Sonoma Pharmaceuticals is a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated therapies. Sonoma Pharmaceutical’s portfolio features unique patented Microcyn® Technology and products to help manage Wound Care, Oral-, Nasal- and Eye Care, First Aid & Personal Protection and Dermatological discomforts like eczema, atopic dermatitis, acne and scars. Unique Anti-Inflammatory-, Antimicrobial- and Regenerative, pH neutral and non-(cyto)toxic technology.  Non-Irritating, non-staining and safe. All natural and made of endogenous active ingredients that do not induce bacterial resistance and support the body’s own healing process. Sonoma Pharmaceuticals has partnered with industry-leading partners in more than 50 countries and is bringing to market unique evidence based, differentiated, patent-protected and high-quality FDA- and CE-marked products for consumer and professional use that are affordable, efficacious and accessible to most every patient. Sonoma is happy to get in touch with potential partners in Europe and North America who have an interest in including our products to their portfolio.

 

  • NL
  • 2018
    On CPHI since
  • 4
    Certificates
  • 100 - 249
    Employees
Company types
Consumer Goods
OTC
Pharmaceutical company
Wholesale/Retail
Primary activities
Biopharmaceutical
Cosmeceuticals
End-product distributor (Wholesale)
Medical Devices
Natural Extracts
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Japan 2024
  • 17 Apr 2024 – 19 Apr 2024
  • East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
  • Visit us at stand 5K-03

Products Featured at CPHI Japan 2024

  • Gramaderm

    Product Gramaderm

    Gramaderm™ solution & hydrogel with patented technology are intended to assist in the treatment of topical mild to moderate acne. It is easy to use and suitable for use by nearly anyone at any time. Men and women, adults or teens, regardless of age. For any and all types of acne, including that on your...
  • Epicyn

    Product Epicyn

    Epicyn™ with patented technology is intended for the management and reduction of new and existing hypertrophic and keloid scars. Epicyn™ forms a protective barrier against physical, chemical and microbial invasion of the scar. It softens, flattens and reduces redness and relieves scar-associated it...
  • Pediacyn

    Product Pediacyn

    Pediacyn™ with patented technology is intended for the management of lesions associated with atopic dermatitis and eczema. It forms a protective barrier against physical, chemical and microbial invasion of atopic dermatitis lesions. It assists in forming a protective barrier against physical, chemical...
  • Ocudox

    Product Ocudox

    Ocudox™ with patented technology is a solution intended to support in the treatment of Blepharitis and the daily hygiene of eyelids and eyelashes. Ocudox™ cleans the eye lids, lashes and periocular skin and assists in removing debris and microorganisms which can cause irritation and ocular surface disease....
  • Microdacyn60 Oral

    Product Microdacyn60 Oral

    Microdacyn60 Oral Care is an electrolysed solution intended for use as an adjuvant for the treatment of mouth and throat infections and the debridement and moistening of mouth lesions that can only heal by secondary intention and thrush. Microdacyn60 Oral Care can be broadly applied within a comprehensive ...
  • Mucoclyns

    Product Mucoclyns

    MucoClyns™ is an electrolysed solution intended for use in emergencies. MucoClyns™ is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to treat immediately after the unexpected exposure to infection risk and before receiving professional medical attention
  • Sinudox

    Product Sinudox

    Sinudox is an electrolysed solution intended for nasal irrigation. For use in the moistening of cuts, abrasions and lacerations located in the nasal cavity. Sinudox is safe on mucous membranes.